Patient-reported outcome measures for chronic obstructive pulmonary disease: The exclusion of people with low literacy skills and learning disabilities

Patient

Volumn 6, Issue 1, 2013, Pages 11-21

  Jahagirdar, Deepa ^a   Kroll, Thilo ^b   Ritchie, Karen ^c   Wyke, Sally ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c HEALTHCARE IMPROVEMENT SCOTLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT TOOL; COGNITION; DYSPNEA; HUMAN; LEARNING DISORDER; MEDICAL RESEARCH; MEDLINE; OUTCOME ASSESSMENT; PATIENT REPORTED OUTCOME MEASURE; PRIORITY JOURNAL; QUESTIONNAIRE; READING; REVIEW; SELF REPORT; SHORT FORM 36; SKILL; SYMPTOM; SYSTEMATIC REVIEW; TOTAL QUALITY MANAGEMENT; VALIDATION PROCESS;

COMORBIDITY; EDUCATIONAL STATUS; GREAT BRITAIN; HUMANS; LEARNING DISORDERS; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT SELECTION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY IMPROVEMENT; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 84874624751     PISSN: 11781653     EISSN: 11781661     Source Type: Journal    
DOI: 10.1007/s40271-013-0004-5     Document Type: Review

References (95)

1. DeWalt DA, Revicki DA. Importance of patient-reported outcomes for quality improvement. Rockville: Agency for Healthcare Research and Quality; 2008. http://qualitymeasures.ahrq.gov/expert/expert-commentary.aspx?id=16466. Accessed 26 Jan 2012.
2. Scottish Government. The healthcare quality strategy for NHS Scotland. Edinburgh: Scottish Government; 2010. http://www.scotland.gov.uk/Resource/Doc/ 311667/0098354.pdf. Accessed 26 Jan 2012.
3. Coyne KS, Tubaro A, Brubaker L, Bavendam T. Development and validation of patient-reported outcomes measures for overactive bladder: a review of concepts. Urology. 2006;68(2 Suppl.):9-16. (Pubitemid 44189488)
4. McKenna GS. Can learning disabilities explain low literacy performance? Gatineau: Human Resources and Social Development Canada; 2010.
5. National Literacy Trust. The Moser report. London: National Literacy Trust; 1999. http://www.literacytrust.org.uk/resources/practical-resources-info/ 1770-the-moser-report. Accessed 26 Jan 2012.
6. Mencap. More about learning disability. London: Mencap; 2008. http://www.mencap.org.uk/all-about-learning-disability/information- professionals/more-about-learning-disability. Accessed 26 Jan 2012.
7. Garcia SF, Hahn EA, Jacobs EA. Addressing low literacy and health literacy in clinical oncology practice. J Support Oncol. 2010;8(2):64-9.
8. Department of Health. Valuing people now: the delivery plan. London: Department of Health; 2009. http://www.dh.gov.uk/prod-consum-dh/groups/dh- digitalassets/documents/digitalasset/dh-093371.pdf. Accessed 26 Jan 2012.
9. United Nations General Assembly. Final report of the Ad Hoc Committee on a Comprehensive and Integral International Convention on the Protection and Promotion of the Rights and Dignity of Persons with Disabilities. New York: UN; 2006.
10. Appleby J, Devlin NJ. Getting the most out of PROMS: putting health outcomes at the heart of NHS decision-making. London: The King's Fund; 2010. http://www.kingsfund.org.uk/publications/proms.html. Accessed 26 Jan 2012.
11. Mencap. Health and Social Care Bill: memorandum submitted by Mencap [HS 18]. London: UK Parliament; 2011. http://www.publications.parliament.uk/pa/ cm201011/cmpublic/health/memo/m18.htm. Accessed 26 Jan 2012.
12. National Institute for Health and Clinical Excellence. Chronic obstructive pulmonary disease: costing report - implementing NICE guidance [CG 101]. London: NICE; 2011. http://www.nice.org.uk/nicemedia/live/13029/53292/ 53292.pdf. Accessed 26 Jan 2012.
13. Fitzpatrick R, Bowling A, Gibbons E, Haywood K, Jenkinson C, Mackintosh A, et al. A structured review of patient-reported measures in relation to selected chronic conditions, perceptions of quality of care and carer impact. Oxford: National Centre for Health Outcomes Development; 2006. http://phi.uhce.ox.ac.uk/pdf/ChronicConditions/DH-REVIEWS-NOVEMBER-2007.pdf. Accessed 26 Jan 2012.
14. Davies N, Gibbons E, Fitzpatrick R. A structured review of patient-reported outcome measures for COPD: an update 2009. Oxford: University of Oxford; 2009. http://phi.uhce.ox.ac.uk/pdf/COPD2009-FINAL.pdf. Accessed 26 Jan 2012.
15. Aaron SD, Vandemheen KL, Clinch JJ, Ahuja J, Brison RJ, Dickinson G, et al. Measurement of short-term changes in dyspnea and disease-specific quality of life following an acute COPD exacerbation. Chest. 2002;121(3):688-96. (Pubitemid 34251429)
16. Schofield MJ, Mishra G. Validity of the SF-12 Compared with the SF-36 Health Survey in Pilot Studies of the Australian Longitudinal Study on Women's Health. J Health Psychol. 1998;3(2):259-71. (Pubitemid 28192800)
17. Maleki-Yazdi MR, Lewczuk CK, Haddon JM, Choudry N, Ryan N. Early detection and impaired quality of life in COPD GOLD stage 0: a pilot study. COPD: J Chronic Obstr Pulm Dis. 2007;4(4):313-20. (Pubitemid 350135866)
18. Singh SJ, Sodergren SC, Hyland ME, Williams J, Morgan MD. A comparison of three disease-specific and two generic health-status measures to evaluate the outcome of pulmonary rehabilitation in COPD. Respir Med. 2001;95(1):71-7. (Pubitemid 32621990)
19. Aiken LS, Butner J, Lockhart CA, Volk-Craft BE, Hamilton G, Williams FG. Outcome evaluation of a randomized trial of the PhoenixCare intervention: program of case management and coordinated care for the seriously chronically ill. J Palliat Med. 2006;9(1):111-26. (Pubitemid 43201775)
20. Williams JE, Singh SJ, Sewell L, Morgan MD. Health status measurement: sensitivity of the self-reported Chronic Respiratory Questionnaire (CRQ-SR) in pulmonary rehabilitation. Thorax. 2003;58(6):515-8. (Pubitemid 36714014)
21. Sprenkle MD, Niewoehner DE, Nelson DB, Nichol KL. The Veterans Short Form 36 questionnaire is predictive of mortality and health-care utilization in a population of veterans with a self-reported diagnosis of asthma or COPD. Chest. 2004;126(1):81-9. (Pubitemid 38943121)
22. Wyrwich KW, Nienaber NA, Tierney WM, Wolinsky FD. Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life. Med Care. 1999;37(5):469-78.
23. Ringbaek T, Martinez G, Lange P. A comparison of the assessment of quality of life with CAT, CCQ, and SGRQ in COPD patients participating in pulmonary rehabilitation. COPD: J Chronic Obstr Pulm Dis. 2012;9(1):12-5.
24. Yount SE, Choi SW, Victorson D, Ruo B, Cella D, Anton S, et al. Brief, valid measures of dyspnea and related functional limitations in chronic obstructive pulmonary disease (COPD). Value Health. 2011;14(2):307-15.
25. Partridge MR, Miravitlles M, Stahl E, Karlsson N, Svensson K, Welte T. Development and validation of the Capacity of Daily Living during the Morning questionnaire and the Global Chest Symptoms Questionnaire in COPD. Eur Respir J. 2010;36(1):96-104.
26. Carod-Arta lF, Coral L, Trizotto D, Moreira C. Self- and proxy-report agreement on the stroke impact scale. Stroke. 2009;40:3308-14.
27. Elliott MN, Beckett MK, Chong K, Hambarsoomians K, Hays RD. How do proxy responses and proxy-assisted responses differ from what Medicare beneficiaries might have reported about their health care? Health Serv Res. 2008;43(3):833-48. (Pubitemid 351623964)
28. Hayley KL, Wangerman T. Using family members or close friends as informants about participation goals for older adults with and without Aphasia. Perspect Neurophysiol Neurogenic Speech Lang Disord. 2012;22(1):12-7.
29. Kaye HS. Inclusion of people with disabilities in the NHIS and NHIS-D: non-response, proxy response, and assisted response. In: Kroll T, Keer D, Placek P, Cyrill J, Hendershot G, editors. Towards best practices for surveying people with disabilities. Hauppage: NovaScience; 2007. p. 105-26.
30. Finlay WM, Lyons E. Methodological issues in interviewing and using self-report questionnaires with people with mental retardation. Psychol Assess. 2001;13(3):319-35. (Pubitemid 32801119)
31. Office of Legislative Policy and Analysis. Healthcare Equality and Accountability Act [H.R. 3459, S. 1833]. Bethesda: Office of Legislative Policy and Analysis; 2003. http://olpa.od.nih.gov/legislation/108/pendinglegislation/ heaa.asp. Accessed 26 Jan 2012.
32. Involve. http://www.involve.org.uk/. Accessed 27 Sep 2012.
33. Nind M. Conducting qualitative research with people with learning, communication and other disabilities: methodological challenges. Southampton: National Centre for Research Methods; 2008.
34. Talking Mats. http://www.talkingmats.com. Accessed 23 Mar 2012.
35. Mencap. Mencap's Make it Clear: a guide to making easy read information. London: Mencap; 2009. http://www.mencap.org.uk/sites/default/files/documents/ 2008-04/make%20it%20clear%20apr09.pdf. Accessed 10 Feb 2012.
36. Hahn EA, Cella D, Dobrez D, Shiomoto G, Marcus E, Taylor SG, et al. The talking touchscreen: a new approach to outcomes assessment in low literacy. Psychooncology. 2004;13(2):86-95. (Pubitemid 38247765)
37. Aguilaniu B, Gonzalez-Bermejo J, Regnault A, Barbosa CD, Arnould B, Mueser M, et al. Disability related to COPD tool (DIRECT): towards an assessment of COPD-related disability in routine practice. Int J COPD. 2011;6:387-98.
38. Ashmore JA, Emery CF, Hauck ER, MacIntyre NR. Marital adjustment among patients with chronic obstructive pulmonary disease who are participating in pulmonary rehabilitation. Heart Lung. 2005;34(4):270-8. (Pubitemid 40968124)
39. Berry MJ, Adair NE, Rejeski WJ. Use of peak oxygen consumption in predicting physical function and quality of life in COPD patients. Chest. 2006;129(6):1516-22. (Pubitemid 43894980)
40. Bauldoff GS, Rittinger M, Nelson T, Doehrel J, Diaz PT. Feasibility of distractive auditory stimuli on upper extremity training in persons with chronic obstructive pulmonary disease. J Cardiopulm Rehabil. 2005;25(1):50-5. (Pubitemid 40315867)
41. Benzo R, Flume PA, Turner D, Tempest M. Effect of pulmonary rehabilitation on quality of life in patients with COPD: the use of SF-36 summary scores as outcomes measures. J Cardiopulm Rehabil. 2000;20(4):231-4. (Pubitemid 30618626)
42. Brightling CE, Monterio W, Green RH, Parker D, Morgan MD, Wardlaw AJ, et al. Induced sputum and other outcome measures in chronic obstructive pulmonary disease: safety and repeatability. Respir Med. 2001;95(12):999-1002. (Pubitemid 34013550)
43. Brown CD, Benditt JO, Sciurba FC, Lee SM, Criner GJ, Mosenifar Z, et al. Exercise testing in severe Emphysema: association with quality of life and lung function. J Chronic Obstruct Pulm Dis. 2008;5(2):117. (Pubitemid 351549829)
44. Carr SJ, Goldstein RS, Brooks D. Acute exacerbations of COPD in subjects completing pulmonary rehabilitation. Chest. 2007;132(1):127-34. (Pubitemid 47068212)
45. Carrieri-Kohlman V, Nguyen HQ, Donesky-Cuenco D, Demir-Deviren S, Neuhaus J, Stulbarg MS. Impact of brief or extended exercise training on the benefit of a dyspnea self-management program in COPD. J Cardiopulm Rehabil. 2005;25(5):275-84. (Pubitemid 41416400)
46. Coultas D, Frederick J, Barnett B, Singh G, Wludyka P. A randomized trial of two types of nurse-assisted home care for patients with COPD. Chest. 2005;128(4):2017-24. (Pubitemid 41507536)
47. Crockett AJ, Cranston JM, Moss JR, Alpers JH. The MOS SF-36 health survey questionnaire in severe chronic airflow limitation: comparison with the Nottingham Health Profile. Quality Life Res. 1996;5(3):330-8. (Pubitemid 26228466)
48. de Torres JP, Pinto-Plata V, Ingenito E, Bagley P, Gray A, Berger R, et al. Power of outcome measurements to detect clinically significant changes in pulmonary rehabilitation of patients with COPD. Chest. 2002;121(4):1092-8. (Pubitemid 34280427)
49. Desikan R, Mason HL, Rupp MT, Skehan M. Health-related quality of life and healthcare resource utilization by COPD patients: a comparison of three instruments. Quality Life Res. 2002;11(8):739-51. (Pubitemid 35388171)
50. Dodd JW, Hogg L, Nolan J, Jefford H, Grant A, Lord VM, et al. The COPD assessment test (CAT): response to pulmonary rehabilitation. A multicentre, prospective study. Thorax. 2011;66(5):425-9.
51. Eaton T, Lewis C, Young P, Kennedy Y, Garrett JE, Kolbe J. Long-term oxygen therapy improves health-related quality of life. Respir Med. 2004;98(4):285-93. (Pubitemid 38443687)
52. Fan VS, Ramsey SD, Make BJ, Martinez FJ. Physiologic variables and functional status independently predict COPD hospitalizations and emergency department visits in patients with severe COPD. COPD: J Chronic Obstruct Pulm Dis. 2007;4(1):29-39. (Pubitemid 46348290)
53. Gross NJ, Nelson HS, Lapidus RJ, Dunn L, Lynn L, Rinehart M, et al. Efficacy and safety of formoterol fumarate delivered by nebulization to COPD patients. Respir Med. 2008;102(2):189-97.
54. Gupta RB, Brooks D, Lacasse Y, Goldstein RS. Effect of rollator use on health-related quality of life in individuals with COPD. Chest. 2006;130(4):1089-95. (Pubitemid 44583739)
55. Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW. A measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987;42(10):773-8. (Pubitemid 17142007)
56. Guyatt GH, Townsend M, Keller J, Singer J, Nogradi S. Measuring functional status in chronic lung disease: conclusions from a randomized control trial. Respir Med. 1991;83(4):293-7.
57. Harper R, Brazier JE, Waterhouse JC, Walters SJ, Jones NM, Howard P. Comparison of outcome measures for patients with chronic obstructive pulmonary disease (COPD) in an outpatient setting. Thorax. 1997;52(10):879-87. (Pubitemid 27473930)
58. Hazell M, Frank T, Frank P. Health related quality of life in individuals with asthma related symptoms. Respir Med. 2003;97(11):1211-8. (Pubitemid 37337018)
59. Hinchcliff M, Beaumont JL, Thavarajah K, Varga J, Chung A, Podlusky S, et al. Validity of two new patient-reported outcome measures in systemic sclerosis: patient-reported outcomes measurement information system 29-item health profile and functional assessment of chronic illness therapy-dyspnea short form. Arthritis Care Res. 2011;63(11):1620-8.
60. Johnson MK, Birch M, Carter R, Kinsella J, Stevenson RD. Measurement of physiological recovery from exacerbation of chronic obstructive pulmonary disease using within-breath forced oscillometry. Thorax. 2007;62(4):299-306. (Pubitemid 46580572)
61. Jones PW, Quirk FH, Baveystock CM. The St George's Respiratory Questionnaire. Respir Med. 1991;85(Suppl. B):25-31 (discussion 33-7).
62. Jones PW, Bosh TK. Quality of life changes in COPD patients treated with salmeterol. Am J Respir Crit Care Med. 1997;155(4):1283-9. (Pubitemid 27172772)
63. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline LN. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34(3):648-54.
64. Jones PW, Brusselle G, Dal Negro RW, Ferrer M, Kardos P, Levy ML, et al. Properties of the COPD assessment test in a cross-sectional European study. Eur Respir J. 2011;38(1):29-35.
65. Jones PW, Tabberer M, Chen WH. Creating scenarios of the impact of COPD and their relationship to COPD Assessment Test (CATTM) scores. BMC Pulm Med. 2011;11:42.
66. Leidy NK, Wilcox TK, Jones PW, Murray L, Winnette R, Howard K, et al. Development of the EXAcerbations of Chronic Obstructive Pulmonary Disease Tool (EXACT): a patient-reported outcome (PRO) measure. Value Health. 2010;13(8):965-75.
67. Mahler DA, Mackowiak JI. Evaluation of the Short-Form 36-item questionnaire to measure health-related quality of life in patients with COPD. Chest. 1995;107(6):1585-9.
68. Martin LL. Validity and reliability of a quality-of-life instrument: the chronic respiratory disease questionnaire. Cli Nurs Res. 1994;3(2):146-56.
69. McGlone S, Venn A, Walters EH, Wood-Baker R. Physical activity, spirometry and quality-of-life in chronic obstructive pulmonary disease. COPD: J Chronic Obstruct Pulm Dis. 2006;3(2):83-8. (Pubitemid 43739179)
70. McKenna SP, Meads DM, Doward LC, Twiss J, Pokrzywinski R, Revicki D, et al. Development and validation of the living with chronic obstructive pulmonary disease questionnaire. Quality Life Res. 2011;20(7):1043-52.
71. Miller JD, Malthaner RA, Goldsmith CH, Goeree R, Higgins D, Cox PG, et al. A randomized clinical trial of lung volume reduction surgery versus best medical care for patients with advanced emphysema: a two-year study from Canada. Annals Thorac Surg. 2006;81(1):314-20. (Pubitemid 41815426)
72. Nagata K, Tomii K, Otsuka K, Tachikawa R, Otsuka K, Takeshita J, et al. Evaluation of the chronic obstructive pulmonary disease assessment test for measurement of health-related quality of life in patients with interstitial lung disease. Respirology. 2012;17(3):506-12.
73. Okubadejo AA, Jones PW, Wedzicha JA. Quality of life in patients with chronic obstructive pulmonary disease and severe hypoxaemia. Thorax. 1996;51(1):44-7. (Pubitemid 26048725)
74. Pakhale S, Wood-Dauphinee S, Spahija J, Collet JP, Maltais F, Bernard S, et al. Combining both generic and disease-specific properties: development of the McGill COPD quality of life questionnaire. COPD: J Chronic Obstruct Pulm Dis. 2011;8(4):255-63.
75. Perez T, Arnould B, Grosbois JM, Bosch V, Guillemin I, Bravo ML, et al. Validity, reliability, and responsiveness of a new short Visual Simplified Respiratory Questionnaire (VSRQ) for health-related quality of life assessment in chronic obstructive pulmonary disease. Int J COPD. 2009;2009(4):9-18.
76. Petrillo J, Cairns J. Development of the EXACT-U: a preference-based measure to report COPD exacerbation utilities. Value Health. 2011;14(4):546-54.
77. Puhan MA, Guyatt GH, Goldstein R, Mador J, McKim D, Stahl E, et al. Relative responsiveness of the Chronic Respiratory Questionnaire, St. George's Respiratory Questionnaire and four other health-related quality of life instruments for patients with chronic lung disease. Respir Med. 2007;101(2):308-16. (Pubitemid 46075963)
78. Punekar YS, Rodriguez-Roisin R, Sculpher M, Jones P, Spencer M. Implications of chronic obstructive pulmonary disease (COPD) on patients' health status: a western view. Respir Med. 2007;101(3):661-9. (Pubitemid 46205904)
79. Ries AL, Make BJ, Lee SM, Krasna MJ, Bartels M, Crouch R, et al. The effects of pulmonary rehabilitation in the national emphysema treatment trial. Chest. 2005;128(6):3799-809. (Pubitemid 43062639)
80. Roth MD, Connett JE, D'Armiento JM, Foronjy RF, Friedman PJ, Goldin JG, et al. Feasibility of retinoids for the treatment of emphysema study. Chest. 2006;130(5):1334-45. (Pubitemid 44786724)
81. Schunemann HJ, Guyatt GH, Griffith L, Stubbing D, Goldstein R. A randomized controlled trial to evaluate the effect of informing patients about their pretreatment responses to two respiratory questionnaires. Chest. 2002;122(5):1701-8. (Pubitemid 35366085)
82. Schunemann HJ, Griffith L, Jaeschke R, Goldstein R, Stubbing D, Guyatt GH. Evaluation of the minimal important difference for the feeling thermometer and the St. George's Respiratory Questionnaire in patients with chronic airflow obstruction. J Clin Epidemiol. 2003;56(12):1170-6. (Pubitemid 37532803)
83. Schunemann HJ, Griffith L, Jaeschke R, Goldstein R, Stubbing D, Austin P, et al. A comparison of the original chronic respiratory questionnaire with a standardized version. Chest. 2003;124(4):1421-9. (Pubitemid 37290053)
84. Sewell L, Singh SJ, Williams JE, Collier R, Morgan MD. Can individualized rehabilitation improve functional independence in elderly patients with COPD? Chest. 2005;128(3):1194-200. (Pubitemid 41324395)
85. Sewell L, Singh SJ, Williams JE, Collier R, Morgan MD. How long should outpatient pulmonary rehabilitation be? A randomised controlled trial of 4 weeks versus 7 weeks. Thorax. 2006;61(9):767-71. (Pubitemid 44369400)
86. Stapleton RD, Nielsen EL, Engelberg RA, Patrick DL, Curtis JR. Association of depression and life-sustaining treatment preferences in patients with COPD. Chest. 2005;127(1):328-34. (Pubitemid 41724593)
87. Tashkin DP, Littner M, Andrews CP, Tomlinson L, Rinehart M, Denis-Mize K. Concomitant treatment with nebulized formoterol and tiotropium in subjects with COPD: a placebo-controlled trial. Respir Med. 2008;102(4):479-87.
88. Tonnel AB, Perez T, Grosbois JM, Verkindre C, Bravo ML, Brun M, et al. Effect of tiotropium on health-related quality of life as a primary efficacy endpoint in COPD. Int J COPD. 2008;3(2):301-10. (Pubitemid 352037890)
89. Tsai CL, Hodder RV, Page JH, Cydulka RK, Rowe BH, Camargo CA Jr. The short-form Chronic Respiratory Disease Questionnaire was a valid, reliable, and responsive quality-of-life instrument in acute exacerbations of chronic obstructive pulmonary disease. J Clin Epidemiol. 2008;61(5):489-97.
90. Viramontes JL, O'Brien B. Relationship between symptoms and health-related quality of life in chronic lung disease. J Gen Intern Med. 1994;9(1):46-8. (Pubitemid 24034271)
91. Williams JE, Singh SJ, Sewell L, Guyatt GH, Morgan MD. Development of a self-reported Chronic Respiratory Questionnaire (CRQ-SR). Thorax. 2001;56(12):954-9. (Pubitemid 33097191)
92. Wilson CB, Jones PW, O'Leary CJ, Cole PJ, Wilson R. Validation of the St. George's Respiratory Questionnaire in bronchiectasis. Am J Respir Crit Care Med. 1997;156(2 Pt 1):536-41. (Pubitemid 27351991)
93. Xue CC, Shergis JL, Zhang AL, Worsnop C, Fong H, Story D, et al. Panax ginseng C.A. Meyer root extract for moderate chronic obstructive pulmonary disease (COPD): study protocol for a randomised controlled trial. Trials. 2011;12:164.
94. Yeo J, Karimova G, Bansal S. Co-morbidity in older patients with COPD: its impact on health service utilisation and quality of life, a community study. Age Ageing. 2006;35(1):33-7. (Pubitemid 43124918)
95. Yohannes AM, Roomi J, Waters K, Connolly MJ. Quality of life in elderly patients with COPD: measurement and predictive factors. Respir Med. 1998;92(10):1231-6. (Pubitemid 28502366)